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The profession was connected closely with the men' s population.
Because of the frequency of illness (1-36/100.000) in the Mediter-
ranean region the brucellosis should always be considered in the
differential diagnosis of prolonged fever.
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Intravascular Device-related Infections in Neurosurgical
Patients: Incidence and Predictors
Nikolaos Syrmos, Vasilios Valadakis, Konstantinos Grigoriou,
Stefanos Patiakas, Dimitrios Arvanitakis. Neurosurgical
Department, Venizeleio General Hospital, Heraklion, Crete,
Greece
Introduction: The rate intravascular device-related infection
varies widely depending most of the times in factors such as- the
nature of the procedure, the patient' s diagnosis, the patient sta-
tus, the nursing comorbidities and other risk factors.
Objective: The objective of our study was to find the frequency
of the colonization of intravascular catheters in neurosurgical pa-
tients.
Materials and Methods: During a five-year period (2002-2007) cul-
tures of the cotton swabs and tips of 150 catheters were done by
qualitative and semiquantitative methods.
Results: The mean colonization rate of the catheter tips was 15,
5%. The most frequent isolates were Gram-positive Staphylococcus
aureus, Staphylococcus epidermidis, CNS etc and Gram-negative
Pseudomonas aeruginosa, Acinetobacter baumanni, etc.
Conclusions: Intravascular catheters are frequently colonized.
These types of infections are a major problem in neurosurgical pa-
tients' . The collaboration between neurosurgeons and laboratory
medical staff is necessary for the best final result.
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The Susceptibility Analysis of Fungal Strains to
Posaconasole in vitro Isolated from Cinical Specimens of
Patients Hospitalized in Warsaw Medical University Central
Clinical Hospital
Ewa Swoboda-Kopec, Sylwia Blachnio, Dariusz Kawecki,
Beata Sulik-Tyszka, Ewa Stelmach, Miroslaw Luczak. Department
of Medical Microbiology, Medical University of Warsaw, Warsaw,
Poland
Introduction: The increasing resistance of fungal strains to anti-
fungal agents is the main reason of research on the new antifun-
gals.
Objectives: The susceptibility analysis of fungal strain isolated
from patients hospitalized in Warsaw Medical University Central
Clinical Hospital in 2007 to Posaconazole in vitro.
Materials and Methods: The clinical material was consisted of:
blood samples 33 (43.4%), respiratory tracts specimens (23.7%),
wound swabs 16 (21%), urine samples 4 (5.3%) and other 5 (6.6%).
Strains were cultured on Sabouraud and CHROMagar media and
identify by ID32C tests. The susceptibility analysis to Posaconazole
was done according to E-tests.
Results: From the total number of 76 positive samples we cultured
87 of fungal strains. The following species were cultured C. gal-
brata 41 (47%), C. albicans 12 (14%), C. krusi 10 (11.5%), C. para-
psilosis 6 (7%), C. inconspicua 4 (4.5%), Saccharomyces cerevisiae
4 (4.5%), other 10 (11.5%). We isolated 83 strains of the yeast like
fungi (95% out of all isolates) and two species of molds (5% of all
isolates): Aspergillus fumigatus 2 strains and Fusarium incarnatum
2. Our results were analyzed according to ARTEMIS Program. The fi-
nal Posaconazole concentration was 0,008 to 32ug/ml. In our study
the break point was 1 ug/ml and it was established as the agent
activity. Posaconazole was active for 83 isolates (95% casus) and it
had the break point 1 ug/ml. The all resistant isolates were from
the same species of C. glabrata. Posaconazole had not been active
for 4 (5%) of isolates.
Conclusions: 10% of C. glabrata isolates were Posaconazole resis-
tant. Posaconazole was active for 95% of isolated strains.
108
Fungiscope – a Global Registry for Rare Fungal Infections
Maria Rüping1, Jörg Vehreschild1, Claudia Beisel1,
Carsten Müller1, Guido Fischer2, Claudia Wickenhauser1,
Oliver Cornely1. 1Uniklinik Köln, Klinik I für Innere Medizin,
Germany; 2RWTH Aachen, Germany
Background: The incidence of invasive fungal infections increases
worldwide, and rare fungi - neither belonging to the genera As-
pergillus, Candida, Pneumocystis or Cryptococcus, nor being en-
demic, is increasingly identified as causative pathogens.
Methods: We are coordinating a global registry for cases of rare
invasive fungi. Our objective is to broaden the knowledge on epi-
demiology, to determine the clinical pattern of disease, to describe
and improve diagnostic procedures and therapeutic regimens, as
well as to facilitate exchange of clinical isolates among the con-
tributors. Entry of retrospective data occurs via a web-based regis-
tration system (MACRO) that focuses on demographic information,
underlying diseases, risk factors, details on the infection, therapy
and outcome. Inclusion criteria include cultural, histopathological,
antigen, or DNA evidence of invasive fungal infection. Infection
due to Aspergillus spp., Candida spp., Cryptococcus neoformans,
Pneumocystis jiroveci or any endemic fungal infection, as well as
mere colonization or other non-invasive infections are exclusion
criteria. For evaluable patient documentations, authorship posi-
tions in resulting publications will be available and a compensation
of €100 each will be paid. If the documentation workload is too
high, centers are encouraged to ask the study office for personnel
to be sent to the site. For isolates made available to the central
laboratory an additional €50 will be paid. Plasma levels of all com-
mon antifungals can be determined from serum, liquor, and other
tissue samples. This service is provided for free to all participating
investigators.
Results: By now, 20 cases of rare invasive fungal infections
have been identified, including Mucoclades corymbifera, Cunning-
hamella bertholletiae, Penicillium marneffei, Rhizomucor pusil-
lus, as well as Acremonium spp., Fusarium spp., Coccidioides spp.,
and Trichoderma spp. Clinical results are partly pending. Most pa-
tients were in an immunocompromised state as a result of their
underlying disease, chemotherapy or transplantation.
Discussion: The clinical relevance of invasive fungal infections by
rare fungi is increasing steadily. In a short period of time, actual
cases from Germany, Austria, Italy and the United Kingdom could
be documented, showing the broad spectrum of pathogens. Further
investigators and coordinators are cordially invited to contribute to
the success of Fungiscope.
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A 61-year Old Immunocompromised Man with Disseminated
Cryptococcosis
Maria Katsiari1, Maria Laskou1, Zoe Roussou2,
Anna Mihalopoulou3, Sotiris Haramoglis4, Nina Maguina1. 1ICU,
2Microbiology Department, 3Pathology Department,
Konstantopoulion Hospital, Athens; 4Urology Department,
Metropolitan Hospital, Athens, Greece
Background: Cryptococcosis is rare and occurs mainly in immuno-
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suppressed patients as those with HIV infection, liver dysfunction,
chronic pulmonary disease, malignancy, sarcoidosis, under corti-
costeroids or dialysis, transplant receivers and diabetics.
Objectives:We present the case of a 61-year old male with vasculi-
tis associated necrotizing glomerulonephritis who developed dis-
seminated cryptococcosis.
Methods: The patient was receiving corticosteroids, cyclophos-
phamide and mycophenolate mofetil for 3,5years due to necro-
tizing glomerulonephritis. He presented with Fournier' s gangrene
(fever, right orchiepididymitis and cellulitis of the lower extrem-
ities). Surgical exploration under broad-spectrum antibiotics was
performed resulting in right orchiectomy. Histological examination
revealed a glanulomatous necrotizing inflammation (Ziehl-Nielsen
negative) and anti Tuberculous agents were added. He was intu-
bated and transferred to ICU after developing oliguria, respiratory
failure and shock. Erythematous lesions and ulcers appeared on
his extremities. The daily dose of prednisolone was increased and
antituberculous drugs were discontinued.
Results: Soon after admission on ICU, cryptococcocus neoformans
was isolated in blood cultures. Brain CT scan and CSF were neg-
ative for cryptococcosis. Tissue biopsy from skin lesions showed
acute panniculitis and fungi spores while culture isolated Crypto-
coccus neoformans. Further testis stains confirmed the presence of
Cryptococcus. Amphotericin B (300mg/day) was added. His condi-
tion improved and he was extubated the 10th day. Six days later he
became septic with respiratory failure and hemodynamic instabil-
ity. Multiresistant Klebsiella pneumoniae was isolated in bronchial
secretions and antibiotic therapy was modified. He developed re-
fractory septic shock and multiorgan failure.
Conclusions: The presence of granulomas in a tissue biopsy should
raise suspicion of autoimmune disorders, malignancy and systemic
infections. Tuberculosis and fungal infections are suggested when
there is history of immunosuppression. Skin lesions in cryptococco-
sis are a sign of dissemination. Secondary infections may compli-
cate and worsen clinical course.
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Genome Analysis Reveals Horizontal Gene Transfer in
Penicillium marneffei
Anna ZHou, Herman Tse, Susanna Lau, Patrick Woo,
Kwok-yung Yuen. Department of Microbiology, The University of
Hong Kong, Hong Kong
Background: Penicillium marneffei is the most important thermal
dimorphic fungus causing respiratory, skin and systemic mycosis in
Southeast Asia. The appearance of the HIV pandemic saw the emer-
gence of the infection as an important opportunistic mycosis in im-
munocompromised patients. Besides HIV positive patients, P. marn-
effei infections have been reported in other immunocompromised
patients. Despite its medical importance and its unusual thermal
dimorphic capability, a large part of the ecology and epidemiology
of P. marneffei remains unknown. The natural habitat of the fun-
gus and its exact route of transmission have not been described.
The advent of complete genome sequencing has led to the recog-
nition of horizontal gene transfer (HGT) as a potentially important
mechanism in the genome evolution in prokaryotes. In comparison,
HGT is less well known in eukaryotes. As there are more and more
eukaryotic whole genome sequencing become available, study of
HGT among eukaryotic is possible.
Objectives: In this poster, we report the horizontal transfer of sev-
eral genes from bacterial lineages that known to populate the soil
environment. These events might be clues to the natural habitat
of P. marneffei and provide insight on its ecology in the natural
environment.
Methods: P. marneffei strain PM1 wan isolated from a HIV-negative
patient with culture-documented penicilliosis in Hong Kong. The
genome was sequenced and assembled. Potentially horizontally
transferred genes are identified by BLAST against NCBI GenBank
database. Sequences of selected P. marneffei genes were manu-
ally corrected. P. marneffei strain PM1 was cultured and the target
genes were sequenced.
Results: A total of 10,060 genes were predicted in the P.marneffei
genome by FGENESH. 9927 informative genes were subjected to
BLAST search, 288 of them were found to have a better align-
ment with the bacterial sequences that the reference A. fumiga-
tus, A.nudulans and N. crassa sequences. 6 genes were identified
to be HGT candidates with good support from the trees constructed
by phylogenetic methods. Phylogenies of HGT candidates are sug-
gestive of transfer mainly from soil bacteria, especially proteobac-
teria.
Conclusion:We were able to identify reliably 6 genes from P. marn-
effei that are potential HGT candidates. And the soil-derived bac-
teria source of these 6 genes provided evidence for P. marneffei to
be a soil organism.
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Drug-resistant Mycobacterium tuberculosis in Argentinian
Children
Griselda Berberian, Lidia Casimir, Laura Lovadina,
Virginia Verdaguer, Maria Teresa Rosanova. Hospital de Pediatria
JP Garrahan, Buenos Aires, Argentina
Background: The emergence of strains of Mycobacterium tuber-
culosis (TB) that are resistant to antimycobacterial agents (Drug-
resistant or DR-TB) is a worldwide problem, whose magnitude is
not well described especially in pediatric patients. TB sensibility
surveillance and risk factors for DR-TB are important issues to con-
sider at the start of treatment.
Objective: To identify the clinical features, risk factors, and out-
come of pediatric patients with DR- TB.
Methods: We performed a retrospective review of medical records
of 19 pediatric patients, with culture confirmed DR-TB, between
January 1998 to December 2007 at the Garrahan Pediatric Hospi-
tal. Drug resistance tests to first line drugs (INH, RMP, SM, EMB)
were performed on Lowenstein- Jensen medium according to the
proportion method or/and Bactec 460 TB system. We defined DR-
TB to those strains of M. tuberculosis resistant to one or more first
line drugs. Depending on the number of drugs, we divided in single
or resistant to 2 or more drugs. In the last group, we recorded the
data in two mutually exclusive categories: multidrug resistant TB
strains (MDR-TB, those resistant at least to INH+RMP), and resistant
to 2 or more drugs (those resistant to any combination other than
INH+RMP)
Results: We had 797 TB cases during 9 years; 299 patients had
bacteriologically confirmed positive culture (37%). Nineteen strains
(6.3%) were DR-TB. Primary resistance was found in 15/19 patients
(80%).The median age of the patients was 84 months (r: 7-168), 9
patients were immunocompromised (8 of them HIV positive). Pul-
monary disease was the most common presentation: 15 patients
(79%). From 19 DR-TB cultures 11 (58%) were mono-resistant (80%
to INH), and 8 (42%) resistant to 2 or more drugs. Six of them (75%)
were MDR-TB. DR- TB infection was more frequent in immunocom-
promised patients 9/19, especially for those that are MDR-TB: 8
patients (89%). Nine (48%) had TB contact, 7 patients (37%) had
previous hospital admission, and 4 patients (21%) previous TB treat-
ment. Two patients (10%) died because of TB, of central nervous
system infection.
Conclusion: DR-TB is infrequent in pediatric patients. The immuno-
compromised state is an important risk factor associated with re-
sistance in this population.
